0000919574-17-002741.txt : 20170313 0000919574-17-002741.hdr.sgml : 20170313 20170313155653 ACCESSION NUMBER: 0000919574-17-002741 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20170313 DATE AS OF CHANGE: 20170313 EFFECTIVENESS DATE: 20170313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: First Eagle Value in Biotechnology Fund (QP), LP CENTRAL INDEX KEY: 0001481559 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-139441 FILM NUMBER: 17685172 BUSINESS ADDRESS: STREET 1: C/O FIRST EAGLE INVESTMENT MANAGEMENT STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 BUSINESS PHONE: (212) 698-3085 MAIL ADDRESS: STREET 1: C/O FIRST EAGLE INVESTMENT MANAGEMENT STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 D/A 1 primary_doc.xml X0707 D/A LIVE 0001481559 First Eagle Value in Biotechnology Fund (QP), LP FIRST EAGLE INVESTMENT MANAGEMENT, LLC 1345 AVENUE OF THE AMERICAS, 48TH FLOOR NEW YORK NY NEW YORK 10105 212-698-3300 DELAWARE None None Limited Partnership true -- -- First Eagle Investment Management, LLC 1345 Avenue of the Americas 48th Floor New York NY NEW YORK 10105 Executive Officer General Partner Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 true 0000919574-16-011860 2005-09-15 true true true false 1000000 Indefinite 68150000 Indefinite false 65 0 true 0 true 0 true The General Partner receives customary management fees as provided in the Issuer's offering documents. true First Eagle Value in Biotechnology Fund (QP), LP /s/ Lynn Perkins Lynn Perkins Authorized Person on behalf of the General Partner 2017-03-13